Together, these findings indicate that activation of the PI3K/AKT pathway, either through increased PDGFRA signalling or aberrant activation of PI3Kα subunits, is a hallmark of PN GBM. The gene discussed is AKT1; the disease is poikiloderma with neutropenia.